• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

获得性AmpC型β-内酰胺酶:意大利长期护理和康复机构中一个新出现的问题。

Acquired AmpC type beta-lactamases: an emerging problem in Italian long-term care and rehabilitation facilities.

作者信息

Migliavacca Roberta, Nucleo Elisabetta, D'Andrea Marco M, Spalla Melissa, Giani Tommaso, Pagani Laura

机构信息

Dipartimento di Scienze Morfologiche Eidologiche e Cliniche, sezione di Microbiologia, Università di Pavia, Pavia, Italy.

出版信息

New Microbiol. 2007 Jul;30(3):295-8.

PMID:17802913
Abstract

We report the multiple detection of Proteus mirabilis isolates, from 4 different long-term care and rehabilitation facilities (LTCRFs) of Northern Italy, resistant to expanded-spectrum cephalosporins and cephamycins and producing an acquired ampC-like beta-lactamase, named CMY-16. Genotyping by PFGE showed that isolates were clonally related to each other, although not identical. In all isolates the bla(CMY16) gene was not transferable by conjugation and was found to be carried on the chromosome. These results revealed multifocal spreading of a CMY-16 producing P. mirabilis clone in Northern Italy and emphasize the emergence of similar acquired resistance determinants in the LTCRFs setting.

摘要

我们报告了从意大利北部4个不同的长期护理和康复机构(LTCRF)分离出奇异变形杆菌,这些菌株对广谱头孢菌素和头孢霉素耐药,并产生一种获得性AmpC样β-内酰胺酶,命名为CMY-16。脉冲场凝胶电泳(PFGE)基因分型显示,分离株彼此克隆相关,尽管并不完全相同。在所有分离株中,bla(CMY16)基因不能通过接合转移,且发现其位于染色体上。这些结果揭示了产CMY-16奇异变形杆菌克隆在意大利北部的多灶性传播,并强调了在LTCRF环境中出现类似获得性耐药决定因素的情况。

相似文献

1
Acquired AmpC type beta-lactamases: an emerging problem in Italian long-term care and rehabilitation facilities.获得性AmpC型β-内酰胺酶:意大利长期护理和康复机构中一个新出现的问题。
New Microbiol. 2007 Jul;30(3):295-8.
2
CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy.CMY-16,一种来自意大利北部奇异变形杆菌多灶单系分离株中CMY/LAT谱系的新型获得性AmpC型β-内酰胺酶。
Antimicrob Agents Chemother. 2006 Feb;50(2):618-24. doi: 10.1128/AAC.50.2.618-624.2006.
3
Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.产AmpC型β-内酰胺酶的多重耐药奇异变形杆菌分离株的传播:流行病学与临床管理
Int J Antimicrob Agents. 2009 Apr;33(4):328-33. doi: 10.1016/j.ijantimicag.2008.09.007. Epub 2008 Dec 17.
4
Molecular epidemiology of ESbetaL producing P. mirabilis strains from a long-term care and rehabilitation facility in Italy.
New Microbiol. 2007 Jul;30(3):362-6.
5
Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.克罗地亚一家长期护理机构中多重耐药奇异变形杆菌的出现。
Wien Klin Wochenschr. 2016 Jun;128(11-12):404-13. doi: 10.1007/s00508-016-1005-x. Epub 2016 May 25.
6
Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.日本迅速传播的产 CTX-M 型超广谱β-内酰胺酶奇异变形杆菌。
Int J Antimicrob Agents. 2010 Oct;36(4):340-2. doi: 10.1016/j.ijantimicag.2010.06.002. Epub 2010 Jul 7.
7
Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland.在波兰广泛传播的奇异变形杆菌克隆中发现了弗氏柠檬酸杆菌AmpC型头孢菌素酶的四种变体,包括新型酶CMY - 14和CMY - 15。
Antimicrob Agents Chemother. 2004 Nov;48(11):4136-43. doi: 10.1128/AAC.48.11.4136-4143.2004.
8
[Plasmid-mediated AMPc producing Proteus mirabilis in the Health Care Area of Santiago de Compostela: molecular and epidemiological analysis by rep-PCR and MALDI-TOF].[圣地亚哥德孔波斯特拉医疗保健区域中产氨苄西林酶奇异变形杆菌的质粒介导:rep-PCR和基质辅助激光解吸电离飞行时间质谱的分子及流行病学分析]
Rev Esp Quimioter. 2012 Jun;25(2):122-8.
9
Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis.奇异变形杆菌中携带 blaCMY-2 的 SXT/R391 样整合子和可移动元件的流行情况。
J Antimicrob Chemother. 2011 Oct;66(10):2266-70. doi: 10.1093/jac/dkr286. Epub 2011 Jul 13.
10
Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases.由于CTX-M型、CMY型以及新型VEB型和抑制剂耐药性TEM型β-内酰胺酶导致产超广谱β-内酰胺酶奇异变形杆菌菌株增加。
J Antimicrob Chemother. 2008 May;61(5):1029-32. doi: 10.1093/jac/dkn056. Epub 2008 Feb 20.

引用本文的文献

1
Mechanisms of Resistance in Gram-Negative Urinary Pathogens: From Country-Specific Molecular Insights to Global Clinical Relevance.革兰氏阴性尿路病原体的耐药机制:从特定国家的分子见解到全球临床相关性
Diagnostics (Basel). 2021 Apr 28;11(5):800. doi: 10.3390/diagnostics11050800.
2
Review on colonization of residents and staff in Italian long-term care facilities by multidrug-resistant bacteria compared with other European countries.与其他欧洲国家相比,意大利长期护理机构中居民和工作人员的多重耐药菌定植情况综述。
Antimicrob Resist Infect Control. 2016 Oct 11;5:33. doi: 10.1186/s13756-016-0136-1. eCollection 2016.
3
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
内科病房中的急性细菌性皮肤和皮肤结构感染:新旧药物
Intern Emerg Med. 2016 Aug;11(5):637-48. doi: 10.1007/s11739-016-1450-6. Epub 2016 Apr 15.
4
Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity.由于临床症状相似,微生物学筛查对于区分携带质粒介导的产AmpCβ-内酰胺酶肠杆菌科细菌和产超广谱β-内酰胺酶(ESBL)肠杆菌科细菌的携带者是必要的。
PLoS One. 2015 Mar 24;10(3):e0120688. doi: 10.1371/journal.pone.0120688. eCollection 2015.
5
AmpC beta-lactamases.AmpC β-内酰胺酶
Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents. doi: 10.1128/CMR.00036-08.
6
Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.对波兰医院分离的肠杆菌科细菌中赋予对新型β-内酰胺类抗生素耐药性的β-内酰胺酶的分子研究。
Antimicrob Agents Chemother. 2008 Jul;52(7):2449-54. doi: 10.1128/AAC.00043-08. Epub 2008 May 5.